AMANDA WONG: Open Payments
NPI 1497307763 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 6 payments from 4 companies in 2025. Trend: 2023 $315 · 2024 $0 · 2025 $269
Food & beverage: $184Education: $85
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $134 |
| Biogen, Inc. | 1 | $97 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $8 |
Products named: ZURZUVAE, Veozah, MYFEMBREE.
Industry payments across NV — which companies pay providers there.
